OPTISCAN BIOMEDICAL CORPORATION – Trademark Portfolio
Entity Type: 03
OPTISCAN BIOMEDICAL CORPORATION holds 17 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 16 filings in this category. The portfolio also extends into Class 41 (Education & Entertainment) across 3 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include OPTISCAN and OPTISCANNER. The owner is based in Alameda, CA.
1105 Atlantic Avenue, Suite 101
Alameda, CA 94501
Showing of trademarks Trademarks
Trademark Classifications
OPTISCAN BIOMEDICAL CORPORATION's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Education; providing of training; entertainment; sporting and cultural activities
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Frequently Asked Questions
How many trademarks does OPTISCAN BIOMEDICAL CORPORATION have?
OPTISCAN BIOMEDICAL CORPORATION has 17 U.S. trademarks filed with the USPTO. Of these, 2 registered, 14 abandoned, 1 cancelled.
What trademark classes does OPTISCAN BIOMEDICAL CORPORATION file in?
OPTISCAN BIOMEDICAL CORPORATION files trademarks across 3 Nice Classification classes. The most active classes are Class 10 (Medical Apparatus), Class 41 (Education & Entertainment), Class 44 (Medical Services). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.
What are OPTISCAN BIOMEDICAL CORPORATION's most well-known trademarks?
OPTISCAN BIOMEDICAL CORPORATION's registered trademark portfolio includes well-known marks such as OPTISCAN and OPTISCANNER. These are among 2 currently registered trademarks in the portfolio.
What is OPTISCAN BIOMEDICAL CORPORATION's trademark registration success rate?
OPTISCAN BIOMEDICAL CORPORATION has a 12% trademark registration rate, with 2 out of 17 resolved applications resulting in successful registration. Currently, 0 applications are pending review.